한글목차

바이오의약품 CMO 및 CRO 시장은 2025년에는 406억 달러로 추정되고, 2032년에는 606억 5,000만 달러에 이를 것으로 예측되며, 2025-2032년 CAGR 5.9%로 성장할 전망입니다.

바이오의약품 CMO(의약품 제조 수탁기관)는 의약품 제조 서비스부터 패키징에 이르기까지 바이오의약품 분야의 다른 기업에 서비스를 제공하는 수탁 기반 기업입니다. 한편, CRO(의약품 개발 업무 수탁 기관)란, 바이오의약품 기업에 연구 서비스를 위탁한다고 하는 형태로 서포트를 제공하는 기업입니다.

시장 역학 :

만성 질환 증가, 창약 개발 증가, 생물 제제 및 바이오시밀러 수요 증가, 아웃소싱 증가 추세, 연구개발 투자 증가, 바이오의약품 산업의 급성장은 세계 바이오 의약품 CMO 및 CRO 시장의 성장을 가속할 것으로 예상되는 주요 요인입니다.

예를 들어, 2023년 2월, 루나포어와 시로나 Dx는 전략적 제휴를 발표하고, 시로나 Dx는 루나포어의 주력 제품인 COMET 공간 생물학 플랫폼을 서비스로 제공하는 미국 최초의 CRO(의약품 개발 업무 수탁기관)가 됩니다. COMET는 시로나 Dx의 연구 서비스 포트폴리오를 보완하여 다양한 분야의 연구자 및 바이오파마 팀의 요구에 대응합니다. COMET는 다양한 분야, 연구 및 의약품 개발의 모든 단계에 있어서, 폭넓은 연구 용도를 제공합니다.

본 조사의 주요 특징

• 본 보고서는 세계의 바이오의약품 CMO 및 CRO 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
• 또한 다양한 부문에서 잠재적인 수익 기회를 밝혀 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계 바이오의약품 CMO 및 CRO 시장의 주요 기업 프로파일을 제공합니다.
• 본 보고서의 인사이트를 통해 마케팅 담당자 및 기업의 경영진은 장래의 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 세계의 바이오의약품 CMO 및 CRO 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자에 대응하고 있습니다.
• 이해관계자는 세계의 바이오의약품 CMO 및 CRO 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차 :

제1장 조사의 목적 및 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• 일관된 기회 지도(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 세계 아웃소싱의 트렌드가 확대
  • 엄격한 규제 틀
  • 바이오의약품 산업의 급속한 성장
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시 및 승인
• PEST 분석
• Porter's Five Forces 분석
• 합병 및 인수 시나리오

제4장 세계의 바이오의약품 CMO 및 CRO 시장 : 원료별(2020-2032년)

• 포유류
• 비포유류

제5장 세계의 바이오의약품 CMO 및 CRO 시장 : 서비스별(2020-2032년)

• 수탁 제조
• 수탁연구

제6장 세계의 바이오의약품 CMO 및 CRO 시장 : 제품별(2020-2032년)

• 바이오로직스
• 바이오시밀러

제7장 세계의 바이오의약품 CMO 및 CRO 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 북아프리카
  • 중앙 아프리카

제8장 경쟁 구도

• Allphase Clinical Research
• AlcheraBio
• Alcami
• Akos Urgent Care
• Agilent
• AGC Biologics
• Affinity Life Sciences, Inc.
• Actimus Bio
• ACI Clinical
• Accumedix, Inc.
• Absorption Systems
• A10 Clinical Solutions
• Albuquerque Clinical Trials(ACT)
• Ajinomoto Bio-Pharma Services
• Advanced Clinical Services LLC
• ACM Global Laboratories
• Accelerated Enrollment Solutions
• AbbVie Contract Manufacturing
• Advanced BioScience Laboratories
• Advanced Clinical Research Institute
• Alliance for Clinical Trials in Oncology

제9장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Biopharmaceutical CMO and CRO Market is estimated to be valued at USD 40.6 Bn in 2025 and is expected to reach USD 60.65 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.

Market Dynamics:

Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.

For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.

Key features of the study:

• This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.

Detailed Segmentation:

• Global Biopharmaceutical CMO and CRO Market, By Source:
  • Mammalian
  • Non-mammalian
• Global Biopharmaceutical CMO and CRO Market, By Service:
  • Contract Manufacturing
  • Contract Research
• Global Biopharmaceutical CMO and CRO Market, By Product:
  • Biologics
  • Biosimilars
• Global Biopharmaceutical CMO and CRO Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Allphase Clinical Research
  • AlcheraBio
  • Alcami
  • Akos Urgent Care
  • Agilent
  • AGC Biologics
  • Affinity Life Sciences, Inc.
  • Actimus Bio
  • ACI Clinical
  • Accumedix, Inc.
  • Absorption Systems
  • A10 Clinical Solutions
  • Albuquerque Clinical Trials (ACT)
  • Ajinomoto Bio-Pharma Services
  • Advanced Clinical Services LLC
  • ACM Global Laboratories
  • Accelerated Enrollment Solutions
  • AbbVie Contract Manufacturing
  • Advanced BioScience Laboratories
  • Advanced Clinical Research Institute
  • Alliance for Clinical Trials in Oncology

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Source
  • Market Snapshot, By Service
  • Market Snapshot, By Product
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing trend of outsourcing across the globe
  • Stringent regulatory framework
  • Rapid growth of the biopharmaceutical industry
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Biopharmaceutical CMO and CRO Market, By Source, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Non-mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

5. Global Biopharmaceutical CMO and CRO Market, By Service, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Contract Manufacturing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Biopharmaceutical CMO and CRO Market, By Product, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biologics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Biosimilars
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Biopharmaceutical CMO and CRO Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Allphase Clinical Research
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AlcheraBio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alcami
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Akos Urgent Care
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AGC Biologics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Affinity Life Sciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Actimus Bio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ACI Clinical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Accumedix, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Absorption Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• A10 Clinical Solutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Albuquerque Clinical Trials (ACT)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ajinomoto Bio-Pharma Services
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced Clinical Services LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ACM Global Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Accelerated Enrollment Solutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Contract Manufacturing
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced BioScience Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced Clinical Research Institute
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alliance for Clinical Trials in Oncology
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us